Biosimilars have been approved in Europe since 2006. With patents on originator biologicals expiring and ever-tightening healthcare budgets biosimilars are likely to take an increasing share of the biologicals market. In light of these facts, this article gives estimated patent expiry dates for just some of
No takes yet. Share an insight, caveat, or question.
GaBI Journal Editor (2015) studied this question.